Sector Gamma AS’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$7.27M Buy
+45,049
New +$7.51M 1.5% 27
2022
Q2
– Sell
-62,000
Closed -$8.23M – 38
2022
Q1
$8.23M Buy
+62,000
New +$7.44M 1.79% 20
2018
Q4
– Sell
-91,453
Closed -$7.24M – 34
2018
Q3
$7.24M Sell
91,453
-308,841
-77% -$23.4M 1.13% 22
2018
Q2
$28.1M Sell
400,294
-2,724
-0.7% -$196K 4.67% 7
2018
Q1
$28.2M Sell
403,018
-45,368
-10% -$3.14M 5.08% 6
2017
Q4
$31.1M Buy
448,386
+78,050
+21% +$5.26M 5.23% 6
2017
Q3
$25.1M Buy
+370,336
New +$23.4M 3.82% 12

Other funds holding AZN

Sector Gamma AS's AZN Position: Q3 2026 in Review

Sector Gamma AS opened a new position in AstraZeneca (AZN) in Q3 2026: 45,049 shares worth $7.27M. The stake represents 1.5% of the portfolio and ranks #27 among its holdings. This is a return to the name: Sector Gamma AS previously reported a position in AZN as recently as Q1 2022.

Sector Gamma AS first reported a position in AZN in Q3 2017 and has held it in 7 quarters since. The position peaked at $31.1M in Q4 2017. 1,446 funds tracked by Wall St. Rank hold AZN as of Q3 2026.

  • Sector Gamma AS held 45,049 shares of AstraZeneca worth $7.27M as of Q3 2026.
  • AstraZeneca was a new Sector Gamma AS position in Q3 2026.
  • AstraZeneca made up 1.5% of Sector Gamma AS's portfolio in Q3 2026, its #27 holding.
  • Sector Gamma AS first reported a position in AstraZeneca in Q3 2017 and has held it in 7 quarters since.
  • Sector Gamma AS's AstraZeneca position peaked at $31.1M in Q4 2017.
  • 1,446 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2026.

Based on Sector Gamma AS's 13F filing for Q3 2026, filed 12 Nov 2026.